S&P 500   3,320.79 (-0.27%)
DOW   29,196.04 (-0.52%)
QQQ   223.28 (-0.04%)
AAPL   316.57 (-0.68%)
FB   221.44 (-0.32%)
MSFT   166.50 (-0.36%)
GOOGL   1,482.25 (+0.18%)
AMZN   1,892.00 (+1.46%)
CGC   24.15 (-2.97%)
NVDA   247.94 (-0.54%)
BABA   222.26 (-2.27%)
MU   58.97 (+2.27%)
GE   11.66 (-1.27%)
TSLA   547.20 (+7.19%)
AMD   51.05 (+0.24%)
T   38.52 (+0.36%)
ACB   2.01 (-5.63%)
F   9.21 (+0.55%)
NFLX   338.11 (-0.46%)
PRI   126.41 (-1.57%)
BAC   34.26 (-1.30%)
DIS   143.56 (-0.53%)
GILD   62.63 (-0.56%)
S&P 500   3,320.79 (-0.27%)
DOW   29,196.04 (-0.52%)
QQQ   223.28 (-0.04%)
AAPL   316.57 (-0.68%)
FB   221.44 (-0.32%)
MSFT   166.50 (-0.36%)
GOOGL   1,482.25 (+0.18%)
AMZN   1,892.00 (+1.46%)
CGC   24.15 (-2.97%)
NVDA   247.94 (-0.54%)
BABA   222.26 (-2.27%)
MU   58.97 (+2.27%)
GE   11.66 (-1.27%)
TSLA   547.20 (+7.19%)
AMD   51.05 (+0.24%)
T   38.52 (+0.36%)
ACB   2.01 (-5.63%)
F   9.21 (+0.55%)
NFLX   338.11 (-0.46%)
PRI   126.41 (-1.57%)
BAC   34.26 (-1.30%)
DIS   143.56 (-0.53%)
GILD   62.63 (-0.56%)
S&P 500   3,320.79 (-0.27%)
DOW   29,196.04 (-0.52%)
QQQ   223.28 (-0.04%)
AAPL   316.57 (-0.68%)
FB   221.44 (-0.32%)
MSFT   166.50 (-0.36%)
GOOGL   1,482.25 (+0.18%)
AMZN   1,892.00 (+1.46%)
CGC   24.15 (-2.97%)
NVDA   247.94 (-0.54%)
BABA   222.26 (-2.27%)
MU   58.97 (+2.27%)
GE   11.66 (-1.27%)
TSLA   547.20 (+7.19%)
AMD   51.05 (+0.24%)
T   38.52 (+0.36%)
ACB   2.01 (-5.63%)
F   9.21 (+0.55%)
NFLX   338.11 (-0.46%)
PRI   126.41 (-1.57%)
BAC   34.26 (-1.30%)
DIS   143.56 (-0.53%)
GILD   62.63 (-0.56%)
S&P 500   3,320.79 (-0.27%)
DOW   29,196.04 (-0.52%)
QQQ   223.28 (-0.04%)
AAPL   316.57 (-0.68%)
FB   221.44 (-0.32%)
MSFT   166.50 (-0.36%)
GOOGL   1,482.25 (+0.18%)
AMZN   1,892.00 (+1.46%)
CGC   24.15 (-2.97%)
NVDA   247.94 (-0.54%)
BABA   222.26 (-2.27%)
MU   58.97 (+2.27%)
GE   11.66 (-1.27%)
TSLA   547.20 (+7.19%)
AMD   51.05 (+0.24%)
T   38.52 (+0.36%)
ACB   2.01 (-5.63%)
F   9.21 (+0.55%)
NFLX   338.11 (-0.46%)
PRI   126.41 (-1.57%)
BAC   34.26 (-1.30%)
DIS   143.56 (-0.53%)
GILD   62.63 (-0.56%)
Log in

NYSE:BAX - Baxter International Stock Price, Forecast & News

$89.73
-0.26 (-0.29 %)
(As of 01/21/2020 04:00 PM ET)
Today's Range
$89.21
Now: $89.73
$89.93
50-Day Range
$81.03
MA: $84.84
$89.99
52-Week Range
$68.69
Now: $89.73
$91.86
Volume4.47 million shs
Average Volume3.41 million shs
Market Capitalization$45.81 billion
P/E Ratio30.21
Dividend Yield0.98%
Beta0.98
Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP07181310
Phone224-948-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$11.13 billion
Cash Flow$4.61 per share
Book Value$14.69 per share

Profitability

Net Income$1.62 billion

Miscellaneous

Employees50,000
Market Cap$45.81 billion
Next Earnings Date1/30/2020 (Estimated)
OptionableOptionable

Receive BAX News and Ratings via Email

Sign-up to receive the latest news and ratings for BAX and its competitors with MarketBeat's FREE daily newsletter.


Baxter International (NYSE:BAX) Frequently Asked Questions

What is Baxter International's stock symbol?

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

How often does Baxter International pay dividends? What is the dividend yield for Baxter International?

Baxter International announced a quarterly dividend on Tuesday, November 19th. Shareholders of record on Friday, December 6th will be paid a dividend of $0.22 per share on Thursday, January 2nd. This represents a $0.88 dividend on an annualized basis and a yield of 0.98%. The ex-dividend date of this dividend is Thursday, December 5th. View Baxter International's Dividend History.

How will Baxter International's stock buyback program work?

Baxter International declared that its board has initiated a stock buyback program on Tuesday, November 13th 2018, which permits the company to buyback $2,000,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to purchase up to 6.1% of its shares through open market purchases. Shares buyback programs are generally an indication that the company's board believes its shares are undervalued.

How were Baxter International's earnings last quarter?

Baxter International Inc (NYSE:BAX) announced its earnings results on Wednesday, October, 31st. The medical instruments supplier reported $0.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.74 by $0.06. The medical instruments supplier earned $2.77 billion during the quarter, compared to the consensus estimate of $2.79 billion. Baxter International had a net margin of 13.80% and a return on equity of 22.99%. Baxter International's revenue for the quarter was up 2.2% on a year-over-year basis. During the same quarter last year, the company posted $0.64 earnings per share. View Baxter International's Earnings History.

When is Baxter International's next earnings date?

Baxter International is scheduled to release their next quarterly earnings announcement on Thursday, January 30th 2020. View Earnings Estimates for Baxter International.

What price target have analysts set for BAX?

15 brokerages have issued 12 month target prices for Baxter International's shares. Their forecasts range from $75.00 to $109.00. On average, they anticipate Baxter International's share price to reach $93.15 in the next year. This suggests a possible upside of 3.8% from the stock's current price. View Analyst Price Targets for Baxter International.

What is the consensus analysts' recommendation for Baxter International?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 4 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Baxter International.

Has Baxter International been receiving favorable news coverage?

Media coverage about BAX stock has been trending positive this week, InfoTrie reports. InfoTrie ranks the sentiment of media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Baxter International earned a news impact score of 2.2 on InfoTrie's scale. They also gave news stories about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Baxter International.

Are investors shorting Baxter International?

Baxter International saw a drop in short interest in the month of December. As of December 13th, there was short interest totalling 4,300,000 shares, a drop of 18.4% from the November 28th total of 5,270,000 shares. Based on an average trading volume of 2,860,000 shares, the days-to-cover ratio is currently 1.5 days. Approximately 0.8% of the company's stock are sold short. View Baxter International's Current Options Chain.

Who are some of Baxter International's key competitors?

What other stocks do shareholders of Baxter International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), Cisco Systems (CSCO), BlackRock (BLK), Johnson & Johnson (JNJ), Verizon Communications (VZ), Honeywell International (HON), Home Depot (HD), Alibaba Group (BABA), Procter & Gamble (PG) and AT&T (T).

Who are Baxter International's key executives?

Baxter International's management team includes the folowing people:
  • Mr. José E. Almeida, Chairman, Pres & CEO (Age 57)
  • Mr. James K. Saccaro, Exec. VP & CFO (Age 46)
  • Mr. Sean Martin, Sr. VP & Gen. Counsel (Age 56)
  • Mr. Giuseppe Accogli, Sr. VP & Pres of Americas (Age 48)
  • Mr. Scott Pleau, Sr. VP of Operations (Age 53)

Who are Baxter International's major shareholders?

Baxter International's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Calamos Advisors LLC (0.19%), Huntington National Bank (0.10%), PGGM Investments (0.09%), Gateway Investment Advisers LLC (0.06%), Nisa Investment Advisors LLC (0.05%) and Zurcher Kantonalbank Zurich Cantonalbank (0.04%). Company insiders that own Baxter International stock include Andrew Frye, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.

Which institutional investors are selling Baxter International stock?

BAX stock was sold by a variety of institutional investors in the last quarter, including Zurcher Kantonalbank Zurich Cantonalbank , Meag Munich Ergo Kapitalanlagegesellschaft MBH, Bangor Savings Bank, United Services Automobile Association, Janney Montgomery Scott LLC, Gateway Investment Advisers LLC, CENTRAL TRUST Co and Calamos Advisors LLC. Company insiders that have sold Baxter International company stock in the last year include Andrew Frye, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Insider Buying and Selling for Baxter International.

Which institutional investors are buying Baxter International stock?

BAX stock was acquired by a variety of institutional investors in the last quarter, including PGGM Investments, Nisa Investment Advisors LLC, FormulaFolio Investments LLC, Huntington National Bank, DNB Asset Management AS, Larson Financial Group LLC, Commerzbank Aktiengesellschaft FI and Baxter Bros Inc.. View Insider Buying and Selling for Baxter International.

How do I buy shares of Baxter International?

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Baxter International's stock price today?

One share of BAX stock can currently be purchased for approximately $89.73.

How big of a company is Baxter International?

Baxter International has a market capitalization of $45.81 billion and generates $11.13 billion in revenue each year. The medical instruments supplier earns $1.62 billion in net income (profit) each year or $3.05 on an earnings per share basis. Baxter International employs 50,000 workers across the globe.View Additional Information About Baxter International.

What is Baxter International's official website?

The official website for Baxter International is http://www.baxter.com/.

How can I contact Baxter International?

Baxter International's mailing address is One Baxter Parkway DF2-1W, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]


MarketBeat Community Rating for Baxter International (NYSE BAX)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  648 (Vote Outperform)
Underperform Votes:  568 (Vote Underperform)
Total Votes:  1,216
MarketBeat's community ratings are surveys of what our community members think about Baxter International and other stocks. Vote "Outperform" if you believe BAX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BAX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel